UBS analyst Joshua Spector lowered the firm’s price target on Sherwin-Williams (SHW) to $415 from $422 and keeps a Buy rating on the shares. UBS is not modeling a major change in the macro in 2026, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHW:
- Sherwin-Williams price target lowered to $370 from $371 at BofA
- Sherwin-Williams upgraded to Buy from Hold at Vertical Research
- Sherwin-Williams price target lowered to $390 from $400 at Mizuho
- Citi upgrades Sherwin-Williams to Buy on better setup into 2026
- Sherwin-Williams upgraded to Buy from Neutral at Citi